| Financial Year |
March 31 2023 |
| Monetary Funds |
90,954,570.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,632,483.66 |
| Accounts Receivable |
585,287,102.28 |
| Advances to Suppliers |
12,968,961.21 |
| Other Receivables |
23,001,051.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
99,737.05 |
| Dividend Receivable |
-- |
| Inventories |
205,074,579.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,398,225.48 |
| Total Current Assets |
974,025,417.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
340,394,790.39 |
| Under-construction Projects |
1,561,656.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,588,517.44 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,492,025.88 |
| Deferred Income Tax Assets |
6,061,460.44 |
| Other Non-Current Assets |
2,690,476.84 |
| Sub-Total of Non-Current Assets |
409,788,927.98 |
| Total Assets |
1,383,814,345.46 |
| Short-Term Loans |
37,892,618.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
103,926,141.57 |
| Accounts Payable |
220,131,966.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,811,415.10 |
| Taxes Payable |
14,273,843.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,053,272.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
214,116.66 |
| Other Current Liabilities |
5,274,525.96 |
| Sub-Total of Current Liabilities |
420,221,262.73 |
| Long-term Loans |
13,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,715,564.76 |
| Total Liabilities |
436,936,827.49 |
| Paid-In Capital(Or Share Stock) |
136,340,000.00 |
| Capital Surplus |
356,887,198.72 |
| Surplus Reserve |
53,020,072.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
400,630,246.63 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
946,877,517.97 |
| Owner's Equity（Stockholder's Equity） |
946,877,517.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,383,814,345.46 |
